Botulinum neurotoxin serotype A (BoNT/A) causes a debilitating and potentially fatal illness known as botulism. The toxin is also a bioterrorism threat, yet no pharmacological antagonist to counteract ...

Some of the world’s most dangerous toxins are being exploited as important new medical therapeutics. Even terrifying things ...

Treatment with botulinum toxin A appears to improve tear production and stability and relieve symptoms in patients with dry ...

Most people with MS who are treated with formulations of botulinum toxin to manage spasticity report being satisfied, a study ...

Learn how trained medical professionals in Hobart use botulinum toxin to manage jaw clenching, bruxism, and masseter ...

Abobotulinum toxin A and prabotulinum toxi A had the most rapid onset of effect on glabellar strain among the botulinum toxin A formulations examined.

This study therefore aimed to quantify the effect of Botulinum toxin type A (BoNT-A) treatment on the accuracy of EMG-based motion detection for post-stroke patients with spasticity. Four stroke ...

To establish the efficacy and safety of botulinum toxin use aimed at improving UOS dysfunction in people with swallowing difficulties (dysphagia) associated with non-progressive and progressive ...

(The Botox brand is not the only injection that uses botulinum toxin type A, but it's arguably the best-known.) In 2024, over 9.8 million Americans got neuromodulator injections, the ASPS reported.

Dystonia involves involuntary muscle contractions, but you're not out of options. Discover how botulinum toxin, DBS, and therapy can restore control.

If Botox doesn’t work, it’s usually due to an incorrect injection technique, a low dose, or if the injection doesn’t contain genuine botulinum toxin, the ingredient in Botox that drives results. Botox ...